- Home
- MRSN vs CCLD Comparison
MRSN vs CCLD Comparison
Compare MRSN & CCLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRSN
- CCLD
- Stock Information
- Founded
- MRSN 2001
- CCLD 1999
- Country
- MRSN United States
- CCLD United States
- Employees
- MRSN N/A
- CCLD N/A
- Industry
- MRSN Biotechnology: Pharmaceutical Preparations
- CCLD Computer Software: Prepackaged Software
- Sector
- MRSN Health Care
- CCLD Technology
- Exchange
- MRSN Nasdaq
- CCLD Nasdaq
- Market Cap
- MRSN 71.9M
- CCLD 66.3M
- IPO Year
- MRSN 2017
- CCLD 2014
- Fundamental
- Price
- MRSN $0.53
- CCLD $3.57
- Analyst Decision
- MRSN Buy
- CCLD Strong Buy
- Analyst Count
- MRSN 7
- CCLD 2
- Target Price
- MRSN $6.00
- CCLD $3.75
- AVG Volume (30 Days)
- MRSN 5.4M
- CCLD 116.0K
- Earning Date
- MRSN 03-07-2025
- CCLD 03-20-2025
- Dividend Yield
- MRSN N/A
- CCLD N/A
- EPS Growth
- MRSN N/A
- CCLD N/A
- EPS
- MRSN N/A
- CCLD N/A
- Revenue
- MRSN $34,837,000.00
- CCLD $111,014,000.00
- Revenue This Year
- MRSN N/A
- CCLD N/A
- Revenue Next Year
- MRSN N/A
- CCLD $1.47
- P/E Ratio
- MRSN N/A
- CCLD N/A
- Revenue Growth
- MRSN N/A
- CCLD N/A
- 52 Week Low
- MRSN $0.49
- CCLD $1.01
- 52 Week High
- MRSN $6.28
- CCLD $4.84
- Technical
- Relative Strength Index (RSI)
- MRSN 32.86
- CCLD 45.17
- Support Level
- MRSN $0.56
- CCLD $3.90
- Resistance Level
- MRSN $0.82
- CCLD $4.75
- Average True Range (ATR)
- MRSN 0.07
- CCLD 0.33
- MACD
- MRSN 0.03
- CCLD -0.06
- Stochastic Oscillator
- MRSN 8.39
- CCLD 17.48
About MRSN Mersana Therapeutics Inc.
Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company using its differentiated and proprietary ADC platforms to develop targeted drugs with increased tolerability and expanded opportunities to deliver meaningful clinical benefits to patients. The Company's early stage programs includes XMT-1660, a Dolasynthen ADC targeting B7-H4, as well as XMT-2056, a STING agonist ADC developed using the Company's Immunosynthen platform and targeting a novel epitope of human epidermal growth factor receptor 2. The Company also has two earlier stage preclinical candidates, XMT-2068 and XMT-2175, both of which leverage the Company's Immunosynthen platform and target tumor-associated antigens.
About CCLD CareCloud Inc.
CareCloud Inc is a healthcare information technology company. It provides a full suite of proprietary cloud-based solutions and related business services. Its Software-as-a-Service platforms include practice management (PM), electronic health record (EHR), business intelligence, telehealth, patient experience management (PXM) solutions, and robotic processing automation (RPA) bots, along with complementary software tools and business services such as revenue cycle management (RCM), premiere healthcare consulting and implementation services, and on-demand workforce staffing capabilities for high-performance medical groups and health systems nationwide. The operating segments of the group are Healthcare IT, which is the key revenue generating segment, and Practice Management.